OBJECTIVES: Long-term risk stratification in patients presenting with acute coronary syndromes (ACS) is possible by measuring cardiac troponin (cTn). The present study examined whether PAPP-A measured in an emergency department (ED) chest pain population in association with conventional and novel high sensitivity cTn (hs-cTnI) assays can predict long-term mortality. METHODS: In 320 patients with cTn measurements the earliest heparinized plasma PAPP-A concentration after presentation was used for risk stratification for death by Kaplan-Meier and Cox analyses. Subgroup analyses using the earliest PAPP-A concentrations were also performed in a cohort of subjects with presentation cTnI < or = 99th percentile but with significantly changing cardiac troponin concentrations as measured by the AccuTnI assay and the hs-cTnI assay (n=45 and 120 subjects, respectively). RESULTS: Subjects with PAPP-A concentrations in the highest tertile were at higher risk for death (HR > 2.00; p < or = 0.05 at 2 years) even after adjusting for cTnI at presentation. In the cohort with cTnI < or = 99th percentile but with changing hs-cTnI concentrations, subjects in the top PAPP-A tertile had a higher probability for death (p=0.02). CONCLUSION: Early measurement of PAPP-A may identify chest pain patients at higher risk for long-term death. Additional prospective ACS studies are required to fully elucidate PAPP-A's role.
OBJECTIVES: Long-term risk stratification in patients presenting with acute coronary syndromes (ACS) is possible by measuring cardiac troponin (cTn). The present study examined whether PAPP-A measured in an emergency department (ED) chest pain population in association with conventional and novel high sensitivity cTn (hs-cTnI) assays can predict long-term mortality. METHODS: In 320 patients with cTn measurements the earliest heparinized plasma PAPP-A concentration after presentation was used for risk stratification for death by Kaplan-Meier and Cox analyses. Subgroup analyses using the earliest PAPP-A concentrations were also performed in a cohort of subjects with presentation cTnI < or = 99th percentile but with significantly changing cardiac troponin concentrations as measured by the AccuTnI assay and the hs-cTnI assay (n=45 and 120 subjects, respectively). RESULTS: Subjects with PAPP-A concentrations in the highest tertile were at higher risk for death (HR > 2.00; p < or = 0.05 at 2 years) even after adjusting for cTnI at presentation. In the cohort with cTnI < or = 99th percentile but with changing hs-cTnI concentrations, subjects in the top PAPP-A tertile had a higher probability for death (p=0.02). CONCLUSION: Early measurement of PAPP-A may identify chest painpatients at higher risk for long-term death. Additional prospective ACS studies are required to fully elucidate PAPP-A's role.
Authors: David A Morrow; Christopher P Cannon; Robert L Jesse; L Kristin Newby; Jan Ravkilde; Alan B Storrow; Alan H B Wu; Robert H Christenson; Fred S Apple; Gary Francis; Wilson Tang Journal: Clin Chem Date: 2007-03-23 Impact factor: 8.327
Authors: Peter A Kavsak; Alice M Newman; Viliam Lustig; Andrew R MacRae; Glenn E Palomaki; Dennis T Ko; Jack V Tu; Allan S Jaffe Journal: Clin Chem Date: 2007-01-04 Impact factor: 8.327
Authors: Peter A Kavsak; Dennis T Ko; Alice M Newman; Viliam Lustig; Glenn E Palomaki; Andrew R MacRae; Allan S Jaffe Journal: Clin Biochem Date: 2007-12-27 Impact factor: 3.281
Authors: Michael D Miedema; Cheryl A Conover; Holly MacDonald; Sean C Harrington; Dedra Oberg; Daniel Wilson; Timothy D Henry; Robert S Schwartz Journal: Am J Cardiol Date: 2008-01-01 Impact factor: 2.778
Authors: Christian J Terkelsen; Claus Oxvig; Bjarne L Nørgaard; Simon Glerup; Tina S Poulsen; Jens F Lassen; Holger J Møller; Leif Thuesen; Erling Falk; Torsten T Nielsen; Henning R Andersen Journal: Am J Cardiol Date: 2008-10-09 Impact factor: 2.778
Authors: Luciano Consuegra-Sanchez; Ivana Petrovic; Juan Cosin-Sales; David W Holt; Michael Christiansen; Juan Carlos Kaski Journal: Clin Chim Acta Date: 2008-01-18 Impact factor: 3.786
Authors: Peter A Kavsak; Andrew Worster; John J You; Mark Oremus; Adell Elsharif; Stephen A Hill; P J Devereaux; Andrew R MacRae; Allan S Jaffe Journal: Clin Biochem Date: 2009-12-21 Impact factor: 3.281
Authors: Sara Di Marino; Nicola Viceconte; Angelo Lembo; Vincenzo Summa; Gaetano Tanzilli; Valeria Raparelli; Giovanni Truscelli; Enrico Mangieri; Carlo Gaudio; Daniel Oscar Cicero Journal: Open Heart Date: 2018-03-10